Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2021 Aug 14.
Published in final edited form as: ACS Infect Dis. 2020 Jul 17;6(8):2110–2119. doi: 10.1021/acsinfecdis.0c00190

Structure-Interaction Relationship of Polymyxins with the Membrane of Human Kidney Proximal Tubular Cells

Xukai Jiang 1, Shuo Zhang 2, Mohammad A K Azad 1, Kade D Roberts 1, Lin Wan 3, Bin Gong 3, Kai Yang 4, Bing Yuan 4, Hemayet Uddin 5, Jingliang Li 6, Philip E Thompson 7, Tony Velkov 8, Jing Fu 2, Lushan Wang 9, Jian Li 1,*
PMCID: PMC7485602  NIHMSID: NIHMS1625955  PMID: 32619094

Abstract

Multidrug-resistant Gram-negative bacteria are a serious global threat to human health. Polymyxins are increasingly used in patients as a last-line therapy to treat infections caused by these life-threatening ‘superbugs’. Unfortunately, polymyxin-induced nephrotoxicity is the major dose-limiting factor and understanding its mechanism is crucial for the development of novel, safer polymyxins. Here, we undertook the first all-atom molecular dynamics simulations of the interaction between four naturally occurring polymyxins A1, B1, M1 and colistin A (representative structural variations of the polymyxin core structure) and the membrane of human kidney proximal tubular cells. All polymyxins inserted spontaneously into the hydrophobic region of the membrane where they were retained, although their insertion abilities varied. Polymyxin A1 completely penetrated into the hydrophobic region of the membrane with a unique folded conformation, whereas the other three polymyxins only inserted their fatty acyl tails into this region. Furthermore, local membrane defects and increased water penetration were induced by each polymyxin, which may represent the initial stage of cellular membrane damage. Finally, the structure-interaction relationship of polymyxins was investigated based on atomic interactions at the cell membrane level. The hydrophobicity at positions 6/7 and stereochemistry at position 3 regulated the interactions of polymyxins with the cell membrane. Collectively, our results provide new mechanistic insights into polymyxin-induced nephrotoxicity at the atomic level and will facilitate the development of new-generation polymyxins.

Keywords: Polymyxins, nephrotoxicity, molecular dynamics, membrane, structure-interaction relationship

Graphical Abstract

graphic file with name nihms-1625955-f0001.jpg

Nephrotoxicity of polymyxins has significantly limited their clinical use. Here we discovered, for the first time, the insertion of polymyxins into the membrane of human renal tubular cells and developed the membrane-based structure-interaction relationship of polymyxins. Our results provide novel insights into the mechanism of polymyxin-induced nephrotoxicity.


The polymyxins (i.e. polymyxin B and colistin) are an ‘old’ class of cyclic lipopeptide antibiotics that are active against Gram-negative bacteria.1 Subsequent to their introduction into the clinic around sixty years ago, a high incidence of nephrotoxicity and neurotoxicity resulted in a decline in their use beginning in the 1970s.1-2 However, the emergence of multidrug-resistant (MDR) Gram-negative ‘superbugs’ over the last two decades, combined with a dwindling antibiotic discovery pipeline, has resulted in a resurgence of their use over the last two decades.2-3 Polymyxins are now increasingly used as a last-line therapy to combat these problematic Gram-negative pathogens, particularly nosocomial infections caused by Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae.4-5 Unfortunately, polymyxin-induced nephrotoxicity occurs in up to 60% of patients following intravenous administration of the currently recommended dosage regimens.6-9 The nephrotoxicity of polymyxin B and colistin is dose-limiting and as such substantially reduces their therapeutic indices. This, in turn, has significantly limited the ability to optimize their use in the clinic based on their pharmacokinetics/pharmacodynamics.10 Such suboptimal use may result in treatment failure and drive the emergence of resistance, further limiting treatment options in patients.11 Therefore, there is an urgent need to identify the molecular mechanism of polymyxin-induced nephrotoxicity and the chemical biology information is crucial for the discovery of novel, safer polymyxins.

Following filtration in the glomeruli, polymyxins undergo tubular reabsorption and accumulate extensively in kidney tubular cells.12-14 Previous studies reported that two major transporters, megalin and PEPT2, play a key role in the reabsorption of polymyxins in kidney tubular cells.15-16 We reported that the significant intracellular accumulation of polymyxins results in mitochondrial damage, release of reactive oxygen species and cellular apoptosis.17-18 Additionally, in a manner that is similar to the permeabilization of the bacterial outer membrane, previous molecular dynamics (MD) simulations have shown that polymyxins are able to insert their hydrophobic tail into other mammalian-like phospholipid bilayers, thereby enhancing membrane permeability.19-20 Polymyxin B has also been shown to induce selective lipid exchange by interacting with the monoanionic phospholipid molecules in model membranes consisting of phosphatidylglycerol and phosphatidic acid;21 binding of polymyxins to the phospholipid bilayer may change the electron density profile of the membrane.22 Together, the current literature suggests that direct interactions between polymyxins and the phospholipid membrane of kidney tubular cells very likely contributes to polymyxin-induced nephrotoxicity. To date, the atomic-level mechanism of this interaction remains unclear, which has significantly limited our understanding of the structure-toxicity relationship of polymyxins and the discovery of new-generation polymyxins.4, 6, 23 In the present study, we simulated a membrane model of human kidney proximal tubular (HK-2) cells24 and employed all-atom MD simulations to systematically investigate the interactions of four naturally occurring polymyxins A1, B1, M1 and colistin A. We demonstrated that upon exposure to polymyxins, the structural and dynamic properties of the membrane were perturbed, which increased the permeability of the membrane to water. Finally, the atomic-scale structure-interaction relationship was elucidated for polymyxins with the kidney cell membrane.

Results

Polymyxins bind to the membrane of human kidney proximal tubular cells

In the initial state of each simulation system, polymyxin A1 (PMA1), B1 (PMB1), M1 (PMM1) and colistin A molecules (Figure 1) rapidly bound to the membrane surface after approximately 2-ns of simulation time, through favourable interactions with the phospholipid headgroups in the outer leaflet of the HK-2 cell membrane (Figure 2A). To examine the role of each polymyxin residue in the initial binding process, the number of contacts between each residue and the membrane components was calculated (Figure 2B). For PMB1, the fatty acyl tail and five Dab residues at positions 1, 3, 5, 8 and 9 formed the majority of the overall contacts with the membrane. In contrast, the residues playing a key role in binding to the membrane were Dab3, Dab5 and Dab9 for colistin A; Dab1 and D-Dab3 for PMA1; and Dab1, Thr7 and Dab9 for PMM1. These results indicate that the positively charged Dab side chains were largely responsible for the initial binding of polymyxins to the membrane surface. In our simulations the polymyxin molecules did not show obvious aggregation on the phospholipid membrane of human kidney tubular cells within the initial binding phase (Figure S1).

Figure 1. Chemical structures of four naturally occurring polymyxins A1, B1, M1 and colistin A.

Figure 1.

Polymyxins are amphipathic lipopeptides consisting of a cyclic heptapeptide ring, a linking tripeptide, and a fatty acyl tail. Five positively charged α,γ-diaminobutyric acid (Dab) residues are located at positions 1, 3, 5, 8, and 9. Positions 3, 6 and 7 represent variable regions within the polymyxin core structure and contain residues with different stereochemistry at position 3 and hydrophobicity at positions 6/7 in the chosen polymyxins (shown in red). L/D-Dab = L/D-2,4-diaminobutyric acid, L-Thr = L-threonine, D-Phe = D-phenylalanine, L-Leu = L-leucine.

Figure 2. Simulation of the binding of polymyxin A1, B1, M1 and colistin A to the human kidney proximal tubular cell membrane.

Figure 2.

(A) The initial configuration of the simulation system. The phosphate atoms of phospholipids are shown in orange spheres and the hydrocarbon tails are shown in grey lines. The polymyxin molecules are shown in grey sticks with red oxygen atoms and blue nitrogen atoms. Water molecules are depicted in lines with red oxygen atoms and white hydrogen atoms. For clarity, the ions are not shown. (B) The number of contacts between polymyxin residues and the membrane during the initial binding process (i.e. the first 2 ns). Contact was considered to be made if the distance between the heavy atom of the polymyxin residue and any heavy atom of membrane lipids was shorter than 5 Å. The contact number was counted with the precision of 10 ps. (C) Lipid composition of the polymyxin-binding regions of the membrane. PC, phosphatidylcholine; PE, phosphatidylethanolamine; PS, phosphatidylserine.

Next, we examined the phospholipids that interacted with each of the four polymyxins to define the binding selectivity. The lipid composition of the polymyxin-binding regions of the membrane are shown in Figure 2C. Of all the phospholipids interacting with each of the four different polymyxins, phosphatidylcholine (PC) was involved in approximately 40% (range: 34 - 44%) whereas phosphatidylethanolamine (PE) was involved in approximately 20% or less (range: 12 - 21%). In contrast, phosphatidylserine (PS) was involved in over 40% of the interactions with PMB1, PMA1 and PMM1 (range: 44 - 50%); and 33% for colistin A. It appears that long-range electrostatic interactions between the Dab residues of each polymyxin molecule and the negatively charged phosphate and carboxyl groups of phospholipids play a major role in the initial binding of polymyxin molecules onto the membrane surface.

Polymyxins insert into the membrane of human kidney proximal tubular cells

The spontaneous insertion of polymyxin molecules into the hydrophobic region of the HK-2 cell membrane was observed across all four types of polymyxins (Figure 3A). Six molecules of polymyxin A1, B1, M1 or colistin A were included in each simulation system and only one polymyxin molecule eventually inserted into membrane. We tracked the relative positions of the inserted polymyxin molecules in the membrane and visualized their insertion kinetics (Figure 3B and S2). After binding to the membrane surface, PMB1, PMM1 and colistin A only inserted their fatty acyl tails into the hydrophobic layer of the membrane, while leaving the cyclic peptide rings above the head groups of the HK-2 membrane lipids. Surprisingly, PMA1 completely penetrated into the hydrophobic core of the membrane after approximately 60-ns of simulation time and adopted a folded conformation therein. The PMA1 folded conformation involved distortion around its D-Dab3 with its hydrophobic segments (i.e. fatty acyl tail and D-Leu6) oriented toward the membrane center (Figure 3A).

Figure 3. Polymyxin A1, B1, M1 and colistin A insert into the hydrophobic region of the kidney cell membrane.

Figure 3.

(A) Snapshots show the insertion of polymyxin A1 B1 M1 and colistin A into the hydrophobic region of the membrane of human kidney proximal tubular cells. The averaged shell of phosphate atoms of the membrane is depicted to show the positions of each polymyxin relative to the headgroups of the membrane lipids. Atoms #1 and #2 represent the last and first carbon atoms of the fatty acyl tail of polymyxins, respectively, and Atom #3 indicates the Cα of D-Phe6 on polymyxin B1 (D-Leu6 in the other three polymyxins). (B) The time-evolved coordinates of the selected carbon atoms along the Z-axis. The line colours correspond to that of the atomic spheres in Fig 3 A.

Polymyxins affect the physical properties of the membrane of human kidney proximal tubular cells

To further understand the effect of polymyxin insertion upon the membrane we examined a number of physical properties of the membrane in the absence and presence of each polymyxin. To this end, the lateral diffusion and order parameters of the phospholipids in the membrane were measured to characterize the dynamic properties of the membrane. In the absence of polymyxin molecules, the average lateral diffusion of the membrane was 7.83 (+/− 0.69) × 10−8 cm2 s−1. In contrast, the average lateral diffusion in the presence of polymyxins decreased to 3.69 (+/− 0.69) × 10−8 cm2 s−1 with PMB1, 5.15 (+/− 0.57) × 10−8 cm2 s−1 with colistin A, 4.11 (+/− 0.65) × 10−8 cm2 s−1 with PMA1 and 4.37 (+/− 0.24) × 10−8 cm2 s−1 with PMM1 (Figure S3); the order parameters of the phospholipid carbon tails were also decreased (Figure S4). These results indicate that polymyxin treatments reduced the membrane fluidity by forming non-covalent contacts that cross-linked neighboring phospholipid molecules. Furthermore, we measured the thickness of the bilayer and the area per lipid to investigate the potential effect of polymyxins on the membrane structure (Table S1). Although the overall membrane thickness and area per lipid molecule did not change significantly during polymyxin treatment, interestingly, the region of the membrane around the polymyxin insertion site was significantly thinned (Figure S5). This indicates that polymyxins primarily caused a localized disorganization of the membrane structure. Furthermore, a considerable number of water molecules entered the hydrophobic region of the membrane as a consequence of the insertion of PMB1 and PMA1; whereas no observable water penetration occurred in the membrane systems treated with colistin A and PMM1 (Figure 4). These results indicate that the insertion of certain polymyxins into the hydrophobic layer of the membrane might enhance water permeability in human kidney proximal tubular cells.

Figure 4. Penetration of water molecules into the membrane due to polymyxin treatment.

Figure 4.

Water molecules are shown with sphere models with red oxygen atoms and white hydrogen atoms. Polymyxins are shown with green stick models and membrane lipids with grey line models. The averaged phosphate shell is shown to indicate the boundary between the membrane and bulk water.

Atomic force microscopy (AFM) was undertaken to measure the membrane roughness of the HK-2 cells with and without polymyxin B treatment (Figure 5). Compared to the control samples, the membrane roughness of HK-2 cells significantly increased following treatment with 25 μM polymyxin B for 60 min, with further increases (a more uneven distribution) with the higher polymyxin B concentration (100 μM). Consistent with the simulation observations, our AFM results indicate the disorganization effect of polymyxins on the HK-2 cell membrane.

Figure 5. Membrane roughness of HK-2 cells following the treatment with polymyxin B for 60 min.

Figure 5.

Ra: averaged roughness; Rq: root-mean-square roughness. Data are presented as means ± S.D. for the measured Ra and Rq of each experiment.

Structure-interaction relationship of polymyxins with the membrane of human kidney proximal tubular cells

To decipher the structure-interaction relationship of polymyxins with the membrane of HK-2 cells, the interaction complex was analyzed at the atomic level and the interaction energy (IE) for each polymyxin residue was determined (Figure 6). PMB1 inserted into the membrane and its fatty acyl tail was embedded into the hydrophobic region of the membrane, where it interacted with the hydrocarbon tails of surrounding phospholipids (IE = −64.4 KJ mol−1). Dab1, Dab3 and Dab5 interacted strongly with the phospholipid head groups in the membrane, with an averaged IE of −264.1 KJ mol−1, −102.9 KJ mol−1 and −219.8 KJ mol−1, respectively. In contrast, the interactions contributed by Dab8 gradually diminished when D-Phe6 started to form hydrophobic contacts with the membrane phospholipids (approximately after 20-ns simulations). Dab9 made only marginal contacts (IE = −7.1 KJ mol−1) with the membrane during the entire penetration trajectory.

Figure 6. Interaction of polymyxin A1, B1, M1 and colistin A with the membrane of human kidney proximal tubular cells.

Figure 6.

The polymyxin molecules are shown in blue sticks; PE, PC and PS are shown in cyan, orange and green sticks, respectively. The key residues of polymyxins responsible for the interaction and their averaged interaction energy are labelled. The color spectrum from yellow to blue represents the increase of interaction intensity. The time points of polymyxin penetration are shown with red arrows.

For colistin A, the fatty acyl tail was also surrounded by and interacted with the hydrocarbon tails of phospholipids (IE = −28.4 KJ mol−1). The positively charged side chains of Dab1 and Dab3 formed electrostatic interactions with the head groups of adjacent phospholipid molecules, albeit, their interactions were not as stable as Dab5 during the insertion phase (i.e. after 40-ns of simulation). Notably, for colistin A, the interaction of D-Leu6 was less than its counterpart D-Phe6 in PMB1 (d-Leu6 IE = −1.9 KJ mol−1 vs. D-Phe6 IE = −44.3 KJ mol−1), whereas Dab8 (IE = −162.1 KJ mol−1) and Dab9 (IE = −241.1 KJ mol−1) of colistin A strongly bound to the head group region of the membrane.

During the membrane insertion of PMA1, both the fatty acyl tail and D-Leu6 formed hydrophobic contacts with the carbon tails of the neighboring phospholipid molecules. The Dab1, Dab5 and Dab8 residues of PMA1 bound to the lipid head groups strongly during the initial phase of membrane penetration (i.e. 40 – 100 ns of simulation), while Dab9 strongly interacted with phospholipid head groups only after PMA1 inserted into the membrane (i.e. 60 – 100 ns of simulation). Interestingly, Thr7 formed two hydrogen bonds with the carbonyl groups of the phospholipid fatty acyl chains. The side chain of D-Dab3 adopted an outward orientation and hardly interacted with the head groups of any membrane phospholipids.

With PMM1, its fatty acyl tail formed hydrophobic interactions with the hydrocarbon tails of membrane phospholipids. Dab1, Dab3, Dab5 and Dab9 made intensive electrostatic interactions with the phosphate and/or carboxyl groups of phospholipids, while the interaction from Dab8 was not very stable when PMM1 inserted into the membrane (i.e. after 25-ns of simulation). Unlike PMA1, Thr7 of PMM1 did not form any hydrogen bonds with any membrane phospholipids due to the longer distance with the carbonyl groups of the phospholipid fatty acyl chains.

Given that the Dab residues of all four polymyxins examined played a dominant role in the overall interaction with the membrane, we mapped their interaction targets onto the membrane phospholipid structures (Figure S6). It is evident that the negatively charged moieties on phospholipid molecules (e.g. phosphate groups of PC, PE and PS; and the carboxyl group of PS) were the main binding sites for polymyxin Dab residues. However, each polymyxin analogue displayed distinct binding patterns. For PMB1 and PMA1, Dab1 predominately bound to the phosphate group of PC. Whereas in colistin A and PMM1 systems Dab1 was found to mainly bind to the carboxyl group of PS (Figure S6). These results indicate that the interaction between the polymyxins and the membrane of human kidney proximal tubular cells was primarily dependent on the electrostatic interactions between the positively charged Dab residues of polymyxins and negatively charged moieties of phospholipids.

Discussion

To date, very little is known on the structure-toxicity relationship of polymyxins. Understanding the mechanism of polymyxin-induced nephrotoxicity is of great importance for the development of novel, safer polymyxins to treat infections caused by MDR Gram-negative pathogens. Here, we employed all-atom MD simulations with an HK-2 cell membrane model to examine the interactions of four naturally occurring polymyxins which contain structural variations at the variable regions within the polymyxin core structure. For the first time, we provide important evidence that polymyxins can spontaneously insert into the hydrophobic region of the HK-2 cytoplasmic membrane. Importantly, the insertion abilities of each polymyxin varied considerably, which was consistent with the nephrotoxicity of each polymyxins in human and mice.25-26 This in turn suggests that such differences may result from stereo-specific structural differences that affect the ability of the polymyxin to insert into, and locally disorganize, the membrane of kidney tubular cells.

Polymyxin-induced nephrotoxicity is eventually a consequence of their significant accumulation within kidney tubular cells wherein they cause mitochondrial damage, release of reactive oxygen species and eventually apoptosis followed by cell death.6, 17-18 However, the initial interaction between the positively charged polymyxins and the negatively charged membrane of kidney tubular cells has never been investigated. Our all-atom molecular dynamics simulation results revealed that, prior to uptake into the tubular cells, polymyxin molecules interact with the outer leaflet of the cell membrane, a process primarily driven by electrostatic interactions between the positively charged Dab residues of polymyxins and the negatively charged phosphate and carboxyl groups of phospholipids (Figure 2). Following this initial interaction, the fatty acyl tails of the polymyxins (and for PMA1, the entire molecule) spontaneously penetrate into the hydrophobic region of the membrane (Figure 3), altering the membrane structural and dynamic properties (Table S1, Figure 4 and S5). Additionally, the AFM measurements experimentally confirmed that polymyxin B treatment disorganized the membrane of HK-2 cells and significantly changed the membrane roughness (Figure 5). Similarly, our simulation findings demonstrated that polymyxins disorganized and penetrated into the membrane of human kidney proximal tubular cells, which can subsequently interfere with cell function and cause toxicity.

A previous investigation utilizing molecular dynamics simulations and the same membrane phospholipid compositions as used in the present study reported that polymyxin B molecules clustered within the kidney cell membrane, cooperatively disorganizing the membrane structure.22 However, in that study the polymyxin molecules were manually placed into the membrane, a situation that may not reflect the real interaction scenario between polymyxin molecules and the kidney cell membrane. In contrast, the insertion of polymyxins in our study occurred spontaneously. In the inserted state, the polar cyclic ring of polymyxins formed a complicated interaction network with the headgroups of phospholipids in the membrane (Figure 6), consistent with previous simulation studies of polymyxin interactions with phospholipid bilayers. 19-20 These polar and electrostatic interactions likely impede further penetration of polymyxins across the membrane, resulting in their accumulation within the outer leaflet of the membrane. Unlike the aggregation of polymyxins which has been observed on the surface of the bacterial outer membrane,20 our results in the present study indicated that the polymyxin molecules inserted into the kidney cell membrane as monomers. This difference is likely due to the structural and chemical differences between lipopolysaccharide (the major component of bacterial outer membrane) and phospholipid molecules (the major component of mammalian cell membrane). Lipopolysaccharide has more negatively charged groups (e.g. typically two phosphate groups per lipid A) and a larger molecular size than the common membrane phospholipids. Therefore, the bacterial outer membrane provides specific binding sites for polymyxins on its surface.

To investigate the structure-interaction relationship of polymyxins with the kidney tubular cell membrane, we utilized four naturally occurring polymyxins that contained representative structural variations (stereochemistry at position 3 and hydrophobicity at positions 6/7) at the variable regions within the polymyxin core structure (Figure 1). Interestingly, minor structural changes at positions 3, 6 and 7 significantly impacted their ability to insert into the tubular cell membrane (Figure 3). PMB1, colistin A and PMM1 only inserted their fatty acyl tails into the hydrophobic region of the membrane, with the cyclic heads of colistin A and PMM1 more favourably bound to the negatively charged membrane surface compared to PMB1 (Figure 3). Considering the only structural differences between colistin A, PMM1 and PMB1 occurred at positions 6 and 7, our results indicate that the structural characteristics at these two positions are key to the binding of the polymyxin cyclic head to the membrane surface. In contrast to d-Leu6-l-Leu7 in colistin A and d-Leu6-l-Thr7 in PMM1, the longer side chain of d-Phe6-l-Leu7 in PMB1 exerted larger steric hindrance, preventing Dab8/Dab9 from interacting with the membrane and thereby inhibiting the surface-binding of the cyclic head of PMB1. Additionally, the repulsively electrostatic interactions between the positively charged side chain of polymyxin Dab residues and the choline group of PC or ethanolamine group of PE is likely another factor in preventing the cyclic ring of PMB1 from approaching the membrane surface. Interestingly, the change in the stereochemistry of Dab3 significantly affected the insertion dynamics of polymyxins. The side chain of l-Dab3 adopted an inward orientation in PMB1, colistin A and PMM1, whereas the side chain of d-Dab3 in PMA1 protruded outwards (Figure 6). Due to the difference in the conformational orientation, d-Dab3 of polymyxin A1 formed little interaction with the membrane lipids, whereas l-Dab3 in PMB1, colistin A and PMM1 interacted with the membrane lipids intensively (Figure 6). Another difference is that the hydroxyl group of l-Thr7 of PMA1 formed two hydrogen bonds with the carbonyl groups of the neighboring phospholipid molecule, whereas l-Leu7 in PMB1 and colistin and l-Thr7 in PMM1 did not form such interactions with the phospholipids. The different interaction patterns resulted in the formation of different conformations when different polymyxins interact with the membrane. Within the folded conformation, the fatty acyl tail and d-Leu6 of PMA1 help to shield a part of structural polarity of the polymyxin molecule, thereby enhancing the penetration of PMA1 into the hydrophobic layer of the kidney tubular cell membrane. PMB1, colistin A, PMM1, PMA1 interacted differently with the various phospholipid molecules of the renal tubular cell membrane, and their different insertion abilities may in part explain their different abilities to induce nephrotoxicity. For example, polymyxin A was shown more nephrotoxic in patients than polymyxin B and colistin.25 In our study PMA1 completely inserted into the membrane whereas PMB1, colistin A and PMM1 only partially inserted; therefore, PMA1 caused more severe membrane damage, which is consistent with the order of their different in vivo nephrotoxicities (Table S2).

Our results clearly show that differences in the structural characteristics of different polymyxins substantially affect their interactions with the membrane of human kidney proximal tubular cells, and it may be possible to minimize the nephrotoxicity of polymyxins by modifying the core structure. Unfortunately, most structural modifications to date that sought to minimize toxicity have also compromised the antimicrobial activity.27 Structure-activity relationship studies of polymyxins have shown that both the Dab residues and the fatty acyl tail are essential for antimicrobial activity, contributing to the electrostatic and hydrophobic interactions, respectively, when binding to the bacterial outer membrane.4, 28 Unfortunately, the key polymyxin residues involved in the interaction with the kidney cell membrane, namely most Dab residues and the hydrophobic tail, are also those which are indispensable for their antibacterial activity. This situation poses a significant challenge when considering how to minimize toxicity while simultaneously retaining activity. Our MD results indicated that shortening the side chain of the Dab residues might reduce the electrostatic interactions between polymyxins and the phospholipids in kidney cell membrane, thereby minimizing the nephrotoxicity. We subsequently conducted MD simulations using our newly developed polymyxin analogue FADDI-287 (Figure S7) which is structurally similar to colistin A but shows much less nephrotoxicity in mice.29 Interestingly, under the same simulation conditions as the other four polymyxins, FADDI-287 molecules only bound to the membrane surface and did not insert into the kidney cell membrane during the simulations (Figure S7). This result further indicates that a polymyxin molecule which cannot insert the kidney cell membrane in our MD systems is very likely less nephrotoxic. More chemical biology research is required to elucidate the complex structure-activity-toxicity relationships of polymyxins in order to uncouple their nephrotoxicity from the antibacterial activity.

To the best of our knowledge, this is the first systematic study to characterize the interactions of structurally different polymyxins with the membrane of human kidney proximal tubular cells using all-atom MD simulations. Different polymyxins can spontaneously insert into the hydrophobic region of the kidney tubular cell membrane with different degrees, perturbing the structure and dynamics of the membrane, and increasing the permeability to water. Importantly, novel structure-interaction relationships of polymyxins were illustrated at the membrane and atomic level. These important findings improve our understanding of the mechanism underlying polymyxin nephrotoxicity and will assist in the development of novel, safer polymyxins to treat life-threatening infections caused by Gram-negative ‘superbugs’.

Methods

System preparation

The lipid composition of kidney epithelial cell membranes reported by Marquez et. al.,24 was used to construct membranes with a composition of 50% PC, 25% PE and 25% PS. In total, 128 phospholipid molecules were employed to construct the membrane model which provided sufficient surface area for the interaction of six polymyxin molecules. There was less than 5% cholesterol in the membrane of kidney epithelial cells,24 and our preliminary simulations revealed that cholesterol did not exert any significant effect on the membrane insertion of polymyxin B1 (Figure S8). Therefore, cholesterol was not included in our membrane model. PC and PE contain a cationic choline or ethanolamine group linked to their phosphate groups, whereas PS contains an anionic serine group linked to its phosphate group. Within the membrane model PS is negatively charged whereas PC/PE are neutrally charged at physiological pH. CHARMM-GUI Membrane Builder was used to assemble the symmetric all-atom phospholipid bilayers model in a tetragonal box.30 TIP3P water molecules and sodium ions were added to hydrate and neutralize the simulation system, respectively.

Four naturally occurring polymyxins, namely polymyxin B1 (PMB1), colistin A, polymyxin A1 (PMA1) and polymyxin M1 (PMM1) were investigated (Figure 1). The 3D structures of polymyxins were constructed in Chem3D and energy minimization was performed on the built structures to relieve any potential steric clashes. The topology parameters of polymyxins were generated in SwissParam server compatible with CHARMM all atom force field.31 Six polymyxin molecules (polymyxin:phospholipid = 1:10) were randomly placed above the bilayer so that the minimum distance between the centre of mass of polymyxin molecules and the surface of the bilayer was larger than 1.5 nm. Correspondingly, the overlapping water molecules and an appropriate amount of sodium ions were removed to maintain the charge neutralization of the whole system. Details of the simulation systems are provided in the Supporting Information (Table S3).

Molecular dynamics simulations

All MD simulations were performed using GROMACS 5.1.2 (www.gromacs.org) with CHARMM36 all-atom lipid parameters.32 For each system, energy minimization was performed using the steepest descent algorithm with the tolerance of 1000 kJ mol−1.nm−1. The standard Membrane Builder six-step equilibration process was carried out by gradually turning off the restraints on the lipid molecules. Then, the simulations were run for 100 ns with three replicates. During the production simulation the temperature was maintained at 310 K using the Nose-Hoover method and the pressure was maintained at 1 bar using the semi-isotropic pressure coupling approach with Parrinello-Rhaman barostat.33-35 Electrostatic interactions were treated using the Particle Mesh Ewald (PME) method with a short-range cut-off of 1.2 nm.36 The cut-off value for van der Waals interactions was set to 1.2 nm. The neighbour list was updated every ten steps. All bonds involving hydrogen atoms were constrained using the LINCS algorithm.37 The time step was set to 2-fs during the production run.

Data analysis and visualization

To define the geometry of each polymyxin molecule, three atoms in the polymyxin core structure were selected. These were the first and last carbon atoms of the fatty acyl tail, and the Cα atom of the residue in position 6 (i.e. d-Phe-6 in polymyxin B1 and d-Leu in the remaining polymyxins A1, M1 and colistin A). The z-axis coordinates of these three atoms were tracked using gmx traj utility to display the insertion kinetics of polymyxins along the simulations. Membrane plugin analysis tool MEMPLUG in VMD was used to calculate the averaged membrane thickness, membrane thickness map and area per lipid molecule.38 All structural snapshots were visualized using PyMOL.39

Measurement of membrane roughness using AFM

Human kidney proximal tubular cells (HK-2) were cultured as we previously described in detail.18 Cells were treated for 60 min with polymyxin B at 25 μM or 100 μM, with another set of untreated cells served as the control group. AFM imaging was conducted by the PicoSPM II AFM (Molecular Imaging) and Dimension Icon AFM (Bruker) in the atmosphere environment using tapping mode. The cantilever length was 115-135 μm, the thickness 2.65-4.15 μm and the resonance frequency 230-410 kHz. The Single Crystal Si tip’s (Bruker Co., US) height was 10-15 μm and the radius 7-10 nm. Samples from all three groups (untreated control, polymyxin B 25 μM and 100 μM) were scanned. Cells in these samples were randomly selected from the glass slide to measure the membrane roughness of the cell. For each group nine roughness measurements were collected and the average roughness (Ra) and root-mean-square roughness (Rq) were used to represent the roughness of the cell membrane. These parameters have been widely used to characterize damages to the cell membrane from environmental toxins.40-41 The wyddion software was employed to analyze the experimental data.42

Supplementary Material

Suppl Material

Acknowledgments

This research was supported by a research grant from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (R01 AI132154). The simulations were performed on the supercomputer cluster MASSIVE 3 at Monash University (Australia) and the HPC Cloud Platform (National Key Research and Development Project, 2016YFB0201702) at Shandong University (China). XKJ is the recipient of a 2019 Faculty Bridging Fellowship, Monash University. JL is an Australia National Health and Medical Research Council (NHMRC) Principal Research Fellow. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health.

Footnotes

Supporting information

Membrane properties characterization; SAR of polymyxin nephrotoxicity; MD simulation systems; motion space of polymyxins; insertion kinetics; plots of mean square diffusion; order parameters of phospholipid in different systems; membrane thickness map; interaction details between polymyxins and membrane.

References

  • 1.Li J, Nation RL, Turnidge JD, Milne RW, Coulthard K, Rayner CR, Paterson DL (2006) Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect. Dis 6, 589–601. [DOI] [PubMed] [Google Scholar]
  • 2.Landman D, Georgescu C, Martin DA, Quale J (2008) Polymyxins revisited. Clin. Microbiol. Rev 21, 449–465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Velkov T, Roberts KD, Thompson PE, Li J (2016) Polymyxins: a new hope in combating Gram-negative superbugs? Future Med. Chem 8, 1017–1025. [DOI] [PubMed] [Google Scholar]
  • 4.Velkov T, Thompson PE, Nation RL, Li J (2010) Structure-activity relationships of polymyxin antibiotics. J. Med. Chem 53, 1898–1916. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Paterson DL, Bonomo RA (2019) Multidrug-resistant Gram-negative pathogens: The urgent need for ‘old’ polymyxins In Polymyxin antibiotics: From laboratory bench to bedside, Springer; Pages 9–13. [DOI] [PubMed] [Google Scholar]
  • 6.Azad MAK, Nation RL, Velkov T, Li J (2019) Mechanisms of polymyxin-induced nephrotoxicity In Polymyxin antibiotics: From laboratory bench to bedside. Springer; Pages 305–319. [DOI] [PubMed] [Google Scholar]
  • 7.Rigatto MH, Behle TF, Falci DR, Freitas T, Lopes NT, Nunes M, Costa LW, Zavascki AP (2015) Risk factors for acute kidney injury (AKI) in patients treated with polymyxin B and influence of AKI on mortality: a multicentre prospective cohort study. J. Antimicrob. Chemother 70, 1552–1557. [DOI] [PubMed] [Google Scholar]
  • 8.Kubin CJ, Ellman TM, Phadke V, Haynes LJ, Calfee DP, Yin MT (2012) Incidence and predictors of acute kidney injury associated with intravenous polymyxin B therapy. J. Infect 65, 80–87. [DOI] [PubMed] [Google Scholar]
  • 9.Hartzell JD, Neff R, Ake J, Howard R, Olson S, Paolino K, Vishnepolsky M, Weintrob A, Wortmann G (2009) Nephrotoxicity associated with intravenous colistin (colistimethate sodium) treatment at a tertiary care medical center. Clin. Infect. Dis 48, 1724–1728. [DOI] [PubMed] [Google Scholar]
  • 10.Nation RL, Forrest A (2019) Clinical pharmacokinetics, pharmacodynamics and toxicodynamics of polymyxins: Implications for therapeutic use In Polymyxin antibiotics: From laboratory bench to bedside, Springer; Pages 219–249. [DOI] [PubMed] [Google Scholar]
  • 11.Kaye KS, Pogue JM, Tran TB, Nation RL, Li J (2016) Agents of last resort: polymyxin resistance. Infect. Dis. Clin. North. Am 30, 391–414. [DOI] [PubMed] [Google Scholar]
  • 12.Li J, Milne RW, Nation RL, Turnidge JD, Smeaton TC, Coulthard K (2003) Use of high-performance liquid chromatography to study the pharmacokinetics of colistin sulfate in rats following intravenous administration. Antimicrob. Agents Chemother 47, 1766–1770. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Yousef JM, Chen G, Hill PA, Nation RL, Li J (2011) Melatonin attenuates colistin-induced nephrotoxicity in rats. Antimicrob. Agents Chemother 55, 4044–4049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Ma Z, Wang J, Nation RL, Li J, Turnidge JD, Coulthard K, Milne RW (2009) Renal disposition of colistin in the isolated perfused rat kidney. Antimicrob. Agents Chemother 53, 2857–2864. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Lu X, Chan T, Xu C, Zhu L, Zhou QT, Roberts KD, Chan HK, Li J, Zhou F (2016) Human oligopeptide transporter 2 (PEPT2) mediates cellular uptake of polymyxins. J. Antimicrob. Chemother 71, 403–412. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Suzuki T, Yamaguchi H, Ogura J, Kobayashi M, Yamada T, Iseki K (2013) Megalin contributes to kidney accumulation and nephrotoxicity of colistin. Antimicrob. Agents Chemother 57, 6319–6324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Azad MA, Roberts KD, Yu HH, Liu B, Schofield AV, James SA, Howard DL, Nation RL, Rogers K, de Jonge MD, Thompson PE, Fu J, Velkov T, Li J (2015) Significant accumulation of polymyxin in single renal tubular cells: a medicinal chemistry and triple correlative microscopy approach. Anal. Chem 87, 1590–1595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Azad MA, Finnin BA, Poudyal A, Davis K, Li J, Hill PA, Nation RL, Velkov T, Li J (2013) Polymyxin B induces apoptosis in kidney proximal tubular cells. Antimicrob. Agents Chemother 57, 4329–4335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Khondker A, Dhaliwal AK, Saem S, Mahmood A, Fradin C, Moran-Mirabal J, Rheinstadter MC (2019) Membrane charge and lipid packing determine polymyxin-induced membrane damage. Commun. Biol 2, 67. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Berglund NA, Piggot TJ, Jefferies D, Sessions RB, Bond PJ, Khalid S (2015) Interaction of the antimicrobial peptide polymyxin B1 with both membranes of E. coli: a molecular dynamics study. PLoS Comput. Biol 11, e1004180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Clausell A, Rabanal F, Garcia-Subirats M, Asuncion Alsina M, Cajal Y (2006) Membrane association and contact formation by a synthetic analogue of polymyxin B and its fluorescent derivatives. J. Phys. Chem. B 110, 4465–4471. [DOI] [PubMed] [Google Scholar]
  • 22.Khondker A, Alsop RJ, Dhaliwal A, Saem S, Moran-Mirabal JM, Rheinstadter MC (2017) Membrane cholesterol reduces polymyxin B nephrotoxicity in renal membrane analogs. Biophys. J 113, 2016–2028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Rabanal F, Cajal Y (2017) Recent advances and perspectives in the design and development of polymyxins. Nat. Prod. Rep 34, 886–908. [DOI] [PubMed] [Google Scholar]
  • 24.Márquez MG, Favale NO, Nieto FL, Pescio LG, Sterin-Speziale N (2012) Changes in membrane lipid composition cause alterations in epithelial cell-cell adhesion structures in renal papillary collecting duct cells. Biochim. Biophys. Acta Biomembr 1818, 491–501. [DOI] [PubMed] [Google Scholar]
  • 25.Swift P, Bushby S (1953) Clinical aspects of the toxicity of polymyxins A, B, and E. Lancet 110–112. [DOI] [PubMed] [Google Scholar]
  • 26.Roberts KD, Azad MA, Wang J, Home AS, Thompson PE, Nation RL, Velkov T, Li J (2015) Antimicrobial activity and toxicity of the major lipopeptide components of polymyxin B and colistin: Last-line antibiotics against multidrug-resistant Gram-negative bacteria. ACS Infect. Dis 1, 568–575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Katsuma N, Sato Y, Ohki K, Okimura K, Ohnishi K, Sakura N (2009) Development of des-fatty acyl-polymyxin B decapeptide analogs with Pseudomonas aeruginosa-specific antimicrobial activity. Chem. Pharm. Bull 57, 332–336. [DOI] [PubMed] [Google Scholar]
  • 28.Velkov T, Roberts KD, Nation RL, Wang J, Thompson PE, Li J (2014) Teaching 'old' polymyxins new tricks: new-generation lipopeptides targeting gram-negative 'superbugs'. ACS Chem. Biol 9, 1172–1177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Sabet M, Tarazi Z, Nolan T, Parkinson J, Rubio-Aparicio D, Roberts KD, Thompson PE, Nation RL, Velkov T, Li J, Hecker SJ, Lomovskaya O, Michael N Dudley MN, Griffith DC (2016) Pharmacology of the novel polymyxin FADDI-287 in preclinical models Poster Saturday-499, ASM Microbe, Boston, MA, USA. [Google Scholar]
  • 30.Jo S, Kim T, Iyer VG, Im W (2008) CHARMM-GUI: a web-based graphical user interface for CHARMM. J. Comput. Chem 29, 1859–1865. [DOI] [PubMed] [Google Scholar]
  • 31.Zoete V, Cuendet MA, Grosdidier A, Michielin O (2011) SwissParam: a fast force field generation tool for small organic molecules. J. Comput. Chem 32, 2359–2368. [DOI] [PubMed] [Google Scholar]
  • 32.Van Der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJ (2005) GROMACS: fast, flexible, and free. J. Comput. Chem 26, 1701–1718. [DOI] [PubMed] [Google Scholar]
  • 33.Parrinello M, Rahman A (1981) Polymorphic transitions in single crystals: A new molecular dynamics method. J. Appl. Phys 52, 7182–7190. [Google Scholar]
  • 34.Nosé S (1984) A molecular dynamics method for simulations in the canonical ensemble. Mol. Phys 52, 255–268. [Google Scholar]
  • 35.Hoover WG (1985) Canonical dynamics: Equilibrium phase-space distributions. Phys. Rev. A 31, 1695. [DOI] [PubMed] [Google Scholar]
  • 36.Darden T, York D, Pedersen L (1993) Particle mesh Ewald: An N· log (N) method for Ewald sums in large systems. J. Chem. Phys 98, 10089–10092. [Google Scholar]
  • 37.Hess B, Bekker H, Berendsen HJ, Fraaije JG (1997) LINCS: a linear constraint solver for molecular simulations. J. Comput. Chem 18, 1463–1472. [Google Scholar]
  • 38.Guixa-González R, Rodriguez-Espigares L, Ramírez-Anguita JM, Carrio-Gaspar P, Martinez-Seara H, Giorgino T, Selent J (2014) MEMBPLUGIN: studying membrane complexity in VMD. Bioinformatics 30, 1478–1480. [DOI] [PubMed] [Google Scholar]
  • 39.Schrodinger LLC, The PyMOL Molecular Graphics System, Version 1.8. 2015.
  • 40.Wang J, Wan Z, Liu W, Li L, Ren L, Wang X, Sun P, Ren L, Zhao H, Tu Q(2009) Atomic force microscope study of tumor cell membranes following treatment with anti-cancer drugs. Biosens. Bioelectron 25, 721–727. [DOI] [PubMed] [Google Scholar]
  • 41.Wang D-C, Chen K-Y, Tsai C-H, Chen G-Y, Chen C-H (2011) AFM membrane roughness as a probe to identify oxidative stress-induced cellular apoptosis. J. Biomech 44, 2790–2794. [DOI] [PubMed] [Google Scholar]
  • 42.Nečas D, Klapetek P (2012) Gwyddion: an open-source software for SPM data analysis. Open Phys. 10, 181–188. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Suppl Material

RESOURCES